Bisphosphonatassoziierte Osteonekrose des Kiefers

Bagan JV, Murillo J, Jimenez Y et al. (2005) Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med 34: 120–123

Bamias A, Kastritis E, Bamia C, Moulopoulos CA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonatly: incidence and risk factors. J Clin Oncol 23: 8580–8587

Benford HL, McGowan NW, Helfrich MH, Nuttall ME, Rogers MJ (2001) Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone 28: 465–473

Black DM, Thompson DE, Bauer DC et al. (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85: 4118–4124

Carter G, Goss AN, Doecke C (2005) Bisphosphonates and avascular necrosis of the jaw: a possible association. Med J Aust 182: 413–415

Carter GD, Goss AN (2003) Bisphosphonates and avascular necrosis of the jaws. Aust Dent J 48: 268

Dearden WF (1901) The causation of phosphorus necrosis. BMJ 2: 408

Dunford JE, Thompson K, Coxon FP et al. (2001) Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 296: 235–242

Durie BG, Katz M, Crowley J (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353: 99–102

Eckert AW, Maurer P, Meyer L, Bilkenroth U, Schubert J (2005) Kieferchirurgische Komplikationen und Management bei Bisphosphonattherapie. Dtsch Zahnärztl Z 60: A92

Estilo CL, Poznak CH van, Williams T et al. (2004) Osteonecrosis of the maxilla and mandible in patients treated with bisphosphonates: a retrospective study. J Clin Oncol 22: 747 (abstract)

Ficarra G, Beninati F, Rubino I, Vannucchi A, Longo G, Tonelli P, Pini Prato G (2005) Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 32: 1123–1128

Fleisch H (1998) Bisphosphonates: mechanisms of action. Endocr Rev 19: 80–100

Fournier P, Boissier S, Filleur S, Guglielmi J, Cabon F, Colombel M, Clezardin P (2002) Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 62:6538–6544

Gonzalez-Moles MA, Bagan-Sebastian JV (2000) Alendronate-related oral mucosa ulcerations. J Oral Pathol Med 29: 514–518

Grötz KA, Diel IJ (2005) Osteonekrose des Kiefers unter Bisphosphonat-Langzeittherapie. Im Focus Onkologie 3: 52–55

Heiman H (1946) Chronic phosphorus poisoning. J Ind Hyg Toxicol 28: 142–150

Hellstein JW, Marek CL (2005) Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63: 682–689

Hoefert S, Eufinger H (2005) [Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates]. Mund Kiefer GesichtsChir 9: 233–238

Jung A, Bisaz S, Fleisch H (1973) The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals. Calcif Tissue Res 11: 269–280

Kassowitz M (1884) Die Behandlung der Rachitis mit Phosphor. Z Klin Med 7: 36–74

Krimmel M, Ferring I, Hoffmann J, Gülicher D, Reinert S (2005) Klinischer Verlauf und Strategien in der Behandlung der Bisphosphonat-induzierten Osteonekrose der Kiefer. Dtsch Zahnärztl Z 60: A93

Lane N, Armitage GC, Loomer P et al. (2005) Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study. J Periodontol 76: 1113–1122

Lin JH (1996) Bisphosphonates: a review of their pharmacokinetic properties. Bone 18: 75–85

Lugassy G, Shaham R, Nemets A, Ben-Dor D, Nahlieli O (2004) Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 117: 440–441

Maerevoet M, Martin C, Duck L (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353: 99–102

Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61: 1115–1117

Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63: 1567–1575

Melo MD, Obeid G (2005) Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy. J Can Dent Assoc 71: 111–113

Menezes AM, Rocha FA, Chaves HV, Carvalho CB, Ribeiro RA, Brito GA (2005) Effect of sodium alendronate on alveolar bone resorption in experimental periodontitis in rats. J Periodontol 76: 1901–1909

Merigo E, Manfredi M, Meleti M, Corradi D, Vescovi P (2005) Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. J Oral Pathol Med 34: 613–617

Migliorati CA, Schubert MM, Peterson DE, Seneda LM (2005) Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104: 83–93

Miles AE (1972) Phosphorus necrosis of the jaw: „phossy jaw“. Br Dent J 133: 203–206

Mönkkönen J, Koponen HM, Ylitalo P (1990) Comparison of the distribution of three bisphosphonates in mice. Pharmacol Toxicol 66: 294–298

Myoung H, Park JY, Choung PH (2001) Effects of a bisphosphonate on the expression of bone specific genes after autogenous free bone grafting in rats. J Periodontal Res 36: 244–251

Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90: 1294–1301

Peters E, Lovas GL, Wysocki GP (1993) Lingual mandibular sequestration and ulceration. Oral Surg Oral Med Oral Pathol 75: 739–743

Purcell PM, Boyd IW (2005) Bisphosphonates and osteonecrosis of the jaw. Med J Aust 182: 417–418

Ramaswamy B, Shapiro CL (2003) Bisphosphonates in the prevention and treatment of bone metastases. Oncology (Williston Park) 17: 1261–1270

Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62: 527–534

Rühlmann D, Kübler AC (2005) Kieferosteomyelitis nach Therapie systemischer osteolytischer Prozesse mit Bisphosphonaten. Quintessenz 56: 679–682

Sanna G, Zampino MG, Pelosi G, Nole F, Goldhirsch A (2005) Jaw avascular bone necrosis associated with long-term use of bisphosphonates. Ann Oncol 16: 1207–1208

Santini D, Vespasiani Gentilucci U, Vincenzi B et al. (2003) The antineoplastic role of bisphosphonates: from basic research to clinical evidence. Ann Oncol 14: 1468–1476

Schirmer I, Peters H, Reichart PA, Durkop H (2005) Bisphosphonate und Osteonekrosen im Kieferbereich. Mund Kiefer GesichtsChir 9: 239–245

Schwabe U, Ziegler R (2004) Mineralstoffpräparate und Osteoporosemittel. In: Schwabe U, Paffrath D (Hrsg) Arzneiverordnungsreport 2004. Springer, Berlin Heidelberg New York, S 697–710

Schwartz HC (1982) Osteonecrosis of the jaws: a complication of cancer chemotherapy. Head Neck Surg 4: 251–253

Shibutani T, Inuduka A, Horiki I, Luan Q, Iwayama Y (2001) Bisphosphonate inhibits alveolar bone resorption in experimentally-induced peri-implantitis in dogs. Clin Oral Implants Res 12: 109–114

Shlomi B, Levy Y, Kleinman S, Better H, Kahn A, Shtabsky A, Chaushu G (2005) [Avascular necrosis of the jaw bone after bisphosphonate therapy]. Harefuah 144: 536–539

Sonis ST, Sonis AL, Lieberman A (1978) Oral complications in patients receiving treatment for malignancies other than of the head and neck. J Am Dent Assoc 97: 468–472

Tänzer J, Wilde F, Liese J, Niederwieser D, Al-Ali HA (2005) Osteonecrosis of the jaw bone in connection with the application of bisphosphonates. Onkologie 28: 210

Tarassoff P, Csermak K (2003) Avascular necrosis of the jaws: risk factors in metastatic cancer patients. J Oral Maxillofac Surg 61: 1238–1239

Vannucchi AM, Ficarra G, Antonioli E, Bosi A (2005) Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma. Br J Haematol 128: 738

Wang J, Goodger NM, Pogrel MA (2003) Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61: 1104–1107

Wegner G (1872) Der Einfluss des Phosphors auf den Organismus. Arch Path Anat (Virchows Arch) 55: 11–44

Whalen JP, O’Donohue N, Krook L, Nunez EA (1973) Pathogenesis of abnormal remodeling of bones: effects of yellow phosphorus in the growing rat. Anat Rec 177: 15–22

Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S (2003) Bisphosphonate-induced osteopetrosis. N Engl J Med 349: 457–463

Zalavras C, Shah S, Birnbaum MJ, Frenkel B (2003) Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis. Crit Rev Eukaryot Gene Expr 13: 221–235